Global Extracorporeal Membrane Oxygenation Machines Market 2024-2028

Description

List of Tables

The extracorporeal membrane oxygenation machines market is forecasted to grow by USD 145.04 mn during 2023-2028, accelerating at a CAGR of 5.92% during the forecast period. The report on the extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of respiratory and heart failure, rising number of new product launches, and growing number of organ transplant procedures.

Technavio's extracorporeal membrane oxygenation machines market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.35%
CAGR	5.92%
Incremental Value	$145.04mn

By Modality

Veno-venous and arterio-venous
Veno-arterial

By Product

ECMO machines
Softwares

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological advancements in ECMO machines as one of the prime reasons driving the extracorporeal membrane oxygenation machines market growth during the next few years. Also, favorable outcomes in patients with respiratory failure due to use of ECMO machines and increasing adoption of ECMO machines in pediatric care and treatment will lead to sizable demand in the market.

The report on the extracorporeal membrane oxygenation machines market covers the following areas:

Extracorporeal membrane oxygenation machines market sizing
Extracorporeal membrane oxygenation machines market forecast
Extracorporeal membrane oxygenation machines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines market vendors that include Abbott Laboratories, Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corp., Edwards Lifesciences Corp., Eurosets Srl, Fresenius SE and Co. KGaA, Gen World Medical Devices, Getinge AB, Johnson and Johnson Services Inc., LivaNova PLC, MC3 Cardiopulmonary, Medtronic, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Sechrist Industries Inc., Senko Medical Instrument Mfg. Co. Ltd., Spectrum Medical Ltd., and Terumo Corp.. Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40185

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Global extracorporeal membrane oxygenation machines market 2018 - 2022
4.2 Modality Segment Analysis 2018 - 2022
4.3 Modality Segment Analysis 2018 - 2022
4.4 Product Segment Analysis 2018 - 2022
4.5 Geography Segment Analysis 2018 - 2022
4.6 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by Modality

6.1 Market segments
6.2 Comparison by Modality
6.3 Veno-venous and arterio-venous - Market size and forecast 2023-2028
6.4 Veno-arterial - Market size and forecast 2023-2028
6.5 Market opportunity by Modality

7 Market Segmentation by Product

7.1 Market segments
7.2 Comparison by Product
7.3 ECMO machines - Market size and forecast 2023-2028
7.4 Softwares - Market size and forecast 2023-2028
7.5 Market opportunity by Product

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 Germany - Market size and forecast 2023-2028
9.9 UK - Market size and forecast 2023-2028
9.10 Canada - Market size and forecast 2023-2028
9.11 China - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Abbott Laboratories
12.4 Braile Biomedica
12.5 Chalice Medical Ltd.
12.6 Eurosets Srl
12.7 Fresenius SE and Co. KGaA
12.8 Getinge AB
12.9 LivaNova PLC
12.10 MC3 Cardiopulmonary
12.11 Medtronic
12.12 MicroPort Scientific Corp.
12.13 Nipro Corp.
12.14 OriGen Biomedical Inc.
12.15 Sechrist Industries Inc.
12.16 Senko Medical Instrument Mfg. Co. Ltd.
12.17 Terumo Corp.

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations